There were no differences in the CVC, V ̄P, and CVC‐reactivity levels for APOE ε4+ participants and APOE ε4− participants after adjusting for sociodemographic and lifestyle factors and the presence of MetS. The gene discussed is APOE; the disease is metabolic syndrome.